NephroDI Therapeutics
Philadelphia, PA
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney. The company was founded in 2017 by Jeff M. Sands, Janet D. Klein, Ish Khanna, and Ram Pillarisetti and is headquartered in Philadelphia, Pennsylvania.
nephrodi.comCompany Details
Founded
- 2017
Employees
- Between 5 - 10 employees
Raised
- $3,600,018
Headquarters Location
- Philadelphia, PA
Public
- No
Acquired
- No
CEO
Rachael A Hagan
Founders
- Janet D. KleinIsh KhannaJeff M. SandsRam Pillarisetti
Company Collections
These are collections NephroDI Therapeutics is a part of. Click on the collection name to view similar companies.
NephroDI Therapeutics' Industries
NephroDI Therapeutics Headquarters Location
Philadelphia, PA 19103
Total Amount Raised: $3,600,018
NephroDI Therapeutics Funding Rounds
Series Unknown
$2,000,000
Seed
$1,600,018
Funding info provided by Diffbot.
NephroDI Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on NephroDI Therapeutics.